Get started Log in

SPEX — Spexis AG Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Brief: Polyphor Appoints Gökhan Batur As CEO
23/01/2020 17:04
Brief: Polyphor: Chairman Of Board Argeris Karabelas Resigns
20/11/2019 06:04
Polyphor's battered stock rises 50% as project gets journal attention
24/10/2019 09:24
Polyphor reinvents itself after abandoning antibiotic trial
04/09/2019 08:03
Swiss stocks - Factors to watch on September 4
04/09/2019 07:12
Brief: Polyphor Cuts 2019 Operating Cost Guidance
04/09/2019 06:03
Swiss stocks - Factors to watch on July 17
17/07/2019 06:23
Brief: Polyphor Closes Phase III PRISM Studies Of Murepavadin Intravenous Formulation
17/07/2019 06:10
Brief: Polyphor Appoints Frank Weber As New Chief Medical And Development Officer
27/06/2019 06:20
Brief: Polyphor Presents New In-Vivo Efficacy And Tolerability Data
07/06/2019 06:02
Europe Research Roundup: Air France-KLM, Intu Properties, Tyman
13/05/2019 08:49
Polyphor: Murepavadin's safety analysis worries Deutsche Bank
13/05/2019 07:36
Swiss stocks - Factors to watch on May 13
13/05/2019 05:24
Brief: Polyphor Temporarily Halts Enrollment In Phase III Studies Of Murepavadin
09/05/2019 17:13
Brief: Polyphor Presents New Data At ECCMID From Its Lead Antibiotic Murepavadin And New Ompta Pol7306
17/04/2019 06:08
Brief: Polyphor: Enrollment Of First Patient In PRISM-UDR Clinical Trial
16/04/2019 06:09
Brief: Polyphor's Shareholders Approve All Motions Proposed At AGM
12/04/2019 16:46
Polyphor: Surges as key drug receives QIDP designation in four new indications
12/04/2019 10:13
Brief: Polyphor's Murepavadin Gets US FDA Qualified Infectious Disease Product Designation
12/04/2019 06:01
Brief: Polyphor Appoints Gökhan Batur As Chief Commercial Officer
09/04/2019 06:09